Related Experiment Videos
Differential expression of APO-1 on human thymocytes: implications for negative selection?
K M Debatin1, D Süss, P H Krammer
1Tumorimmunology Program/Division of Immunogenetics, German Cancer Research Center, Heidelberg.
European Journal of Immunology
|March 1, 1994
Summary
The APO-1 pathway, crucial for programmed cell death, is expressed on most human thymocytes but decreases in mature T cells. A new thymocyte subset (TCR(im)/APO-1hi) shows high APO-1, indicating its role in T cell negative selection.
Area of Science:
- Immunology
- Cell Biology
- Developmental Biology
Background:
- Negative selection is vital for T cell development in the thymus, eliminating self-reactive cells via apoptosis.
- The APO-1 pathway is a known mechanism for apoptosis induction in peripheral lymphoid cells.
Purpose of the Study:
- To investigate the expression and role of the APO-1 pathway during human thymocyte development.
- To identify thymocyte subpopulations expressing APO-1 and their potential involvement in negative selection.
Main Methods:
- Flow cytometry analysis of human thymocytes.
- Immunophenotyping using markers such as APO-1, TCR alpha/beta, CD28, CD44, CD69, and Bcl-2.
Main Results:
- APO-1 is constitutively expressed on most human thymocytes.
- APO-1 expression is downregulated at a mature thymocyte stage (TCR(hi)) characterized by CD28hi, CD44hi, CD69hi, and Bcl-2 upregulation.
- A novel thymocyte subpopulation (TCR(im)/APO-1hi) was identified, exhibiting high APO-1 levels and containing a significant fraction of dead cells.
Conclusions:
- The APO-1 pathway is dynamically regulated during human thymocyte ontogeny.
- The TCR(im)/APO-1hi subpopulation suggests a role for the APO-1 pathway in the negative selection of intrathymically activated T cells.